PATENT ASSIGNMENT AGREEMENTPatent Assignment Agreement • November 9th, 2011 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New Jersey
THIS PATENT ASSIGNMENT AGREEMENT (the “Agreement”) is made and is effective as of September 15, 2011 (the “Effective Date”), by and between UNIGENE LABORATORIES, INC., a Delaware corporation having a place of business at 110 Little Falls Road, Fairfield, NJ 07004 (hereinafter referred to as “Company”) and KIERAN MURPHY, LLC, having its office at 100 West Road, Suite 300, Towson, MD 21210 (hereinafter referred to as “Murphy”).
TARSA THERAPEUTICS, INC. FIRST OMNIBUS AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT, NOTES AND WARRANTSNote and Warrant Purchase • November 9th, 2011 • Unigene Laboratories Inc • Medicinal chemicals & botanical products
This OMNIBUS AMENDMENT TO THE NOTE AND WARRANT PURCHASE AGREEMENT, NOTES AND WARRANTS (this “Amendment”) is made and entered into this 8th day of April, 2011, by and among Tarsa Therapeutics, Inc., a Delaware corporation (the “Company”), and Purchasers party to that certain Note Purchase Agreement dated as of September 29, 2010, by and among the Company and the Purchasers named therein (as amended, the “Purchase Agreement”). Capitalized terms used and not specifically defined herein shall have the meaning given to them in the Agreement.
DEVELOPMENT SERVICES AND CLINICAL SUPPLY AGREEMENT Between GLAXOSMITHKLINE LLC And UNIGENE LABORATORIES, INC.Development Services and Clinical Supply Agreement • November 9th, 2011 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Pennsylvania
THIS DEVELOPMENT SERVICES AGREEMENT (this “Agreement”) is entered into as of this August 3, 2011 (the “Effective Date”), by and between GlaxoSmithKline LLC, a Delaware limited liability company (“GSK”), and Unigene Laboratories, Inc., a Delaware corporation (“Unigene”). GSK and Unigene are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
MASTER SERVICES AGREEMENTMaster Services Agreement • November 9th, 2011 • Unigene Laboratories Inc • Medicinal chemicals & botanical products
THIS MASTER SERVICES AGREEMENT (this “Agreement”) made this April 7, 2011, by and between Unigene Laboratories, Inc., with its principal place of business located at 83 Fulton Street, Boonton, NJ 07005 (“UNIGENE”), and Tarsa Therapeutics, Inc., with its principal place of business located at Eight Penn Center, 1628 JFK Blvd., Suite 1400, Philadelphia, PA 19103-2124 (“TARSA”)
